INO · Inovio Pharmaceuticals
The AI's read
A share-price jump alone does not show that Inovio's business changed. The article gives no new company results, product news, or other company-specific reason for the move.
Inovio shares rose 293% in Friday's after-hours session. The article gives no company update to explain the move or change its business outlook.
A share-price jump alone does not show that Inovio's business changed. The article gives no new company results, product news, or other company-specific reason for the move.
Capricor shares rose 12% in Friday's after-hours session. The article gives no company update that changes its business outlook.
Acumen shares rose 10%, and the article says its Q3 report came out 4 days earlier. It gives no report details, so it does not change how we read Acumen's business.
PRF Technologies shares rose 10% in Friday's after-hours session. The article gives no company update that changes its business outlook.
Precigen shares fell 27% in Friday's after-hours session. The article gives no company update or reason for the fall, so it does not change the business outlook.
Matinas BioPharma shares fell 22% in Friday's after-hours session. The article gives no company update or reason for the fall, so it does not change the business outlook.
Follow Inovio Pharmaceuticals (INO) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for INO